Stat1 acetylation inhibits inducible nitric oxide synthase expression in interferon-γ-treated RAW264.7 murine macrophages

Surgery

Volumn 142, Issue 2, 2007, Pages 156-162

  Guo, Lucie ^a   Guo, Hongtao ^a   Gao, Chengjiang ^a   Mi, Zhiyong ^a   Russell, William B ^a   Kuo, Paul C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MESSENGER RNA; NITRITE; PROTEIN; STAT1 PROTEIN; TRICHOSTATIN A; VALPROIC ACID;

ACETYLATION; ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; IMMUNOPRECIPITATION; MACROPHAGE ACTIVATION; MEDICAL ASSESSMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SEPSIS; TRANSCRIPTION REGULATION;

ACETYLATION; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INTERFERON TYPE II; MACROPHAGES; MICE; NITRIC OXIDE SYNTHASE TYPE II; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); STAT1 TRANSCRIPTION FACTOR;

EID: 34547609011     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2007.02.016     Document Type: Article

References (22)

1. Xie Q.W., and Nathan C. The high output nitric oxide pathway: role and regulation. J Leukocyte Biol 56 (1994) 576-582
2. Doursout M.F., Kilbourn R.G., Hartley C.J., and Chelly J.E. Effects of N-methyl-L-arginine on cardiac and regional blood flow in a dog endotoxin shock model. J Crit Care 15 (2000) 22-29
3. Kilbourn R.G., Traber D.L., and Szabo C. Nitric oxide and shock. Dis Mon 43 (1997) 277-348
4. Oddis C.V., Simmons R.L., Hattler B.G., and Finkel M.S. Chronotropic effects of cytokines and the nitric oxide synthase inhibitor, L-NMMA, on cardiac myocytes. Biochem Biophys Res Commun 205 (1994) 992-997
5. Schindler C., and Darnell Jr. J.E. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 64 (1995) 621-651
6. Kouzarides T. Acetylation: a regulatory modification to rival phosphorylation?. EMBO J 19 (2000) 1176-1179
7. Ganster R.W., Guo Z., Shao L., and Geller D.A. Differential effects of TNF-alpha and IFN-gamma on gene transcription mediated by NF-kappaB-Stat1 interactions. J Interferon Cytokine Res 25 (2005) 707-719
8. Lin A.W., Chang C.C., and McCormick C.C. Molecular cloning and expression of an avian macrophage nitric-oxide synthase cDNA and the analysis of the genomic 5'-flanking region. J Biol Chem 271 (1996) 11911-11919
9. Chu S.C., Marks-Konczalik J., Wu H.P., Banks T.C., and Moss J. Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. Biochem Biophys Res Commun 248 (1998) 871-878
10. Shuai K., and Liu B. Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol 3 (2003) 900-911
11. Platanias L.C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5 (2005) 375-386
12. Tedeschi E., Menegazzi M., Margotto D., Suzuki H., Forstermann U., and Kleinert H. Anti-inflammatory actions of St. John's Wort: inhibition of human inducible nitric-oxide synthase expression by down-regulating signal transducer and activator of transcription-1alpha (STAT-1alpha) activation. J Pharmacol Exp Ther 307 (2003) 254-261
13. Tedeschi E., Menegazzi M., Yao Y., Suzuki H., Forstermann U., and Kleinert H. Green tea inhibits human inducible nitric-oxide synthase expression by down-regulating signal transducer and activator of transcription-1alpha activation. Mol Pharmacol 65 (2004) 111-120
14. Yao Y., Hausding M., Erkel G., Anke T., Forstermann U., and Kleinert H. Sporogen, S14-95, and S-curvularin, three inhibitors of human inducible nitric-oxide synthase expression isolated from fungi. Mol Pharmacol 63 (2003) 383-391
15. Gao J., Morrison D.C., Parmely T.J., Russell S.W., and Murphy W.J. An interferon-gamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide. J Biol Chem 272 (1997) 1226-1230
16. Darville M.I., and Eizirik D.L. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Diabetologia 41 (1998) 1101-1108
17. Teng X., Zhang H., Snead C., and Catravas J.D. Molecular mechanisms of iNOS induction by IL-1 beta and IFN-gamma in rat aortic smooth muscle cells. Am J Physiol Cell Physiol 282 (2002) C144-C152
18. Kleinert H., Wallerath T., Fritz G., Ihrig-Biedert I., Rodriguez-Pascual F., Geller D.A., et al. Cytokine induction of NO synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1 and NF-kappaB-signaling pathways. Br J Pharmacol 125 (1998) 193-201
19. Blanchette J., Jaramillo M., and Olivier M. Signalling events involved in interferon-gamma-inducible macrophage nitric oxide generation. Immunology 108 (2003) 513-522
20. Ganster R.W., Taylor B.S., Shao L., and Geller D.A. Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B. Proc Natl Acad Sci U S A 98 (2001) 8638-8643
21. Meraz M.A., White J.M., Sheehan K.C., Bach E.A., Rodig S.J., Dighe A.S., et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84 (1996) 431-442
22. Kumar B.R.P., Swaminathan V., Banerjee S., and Kundu T.K. P300-mediated acetylation of human transcriptional coactivator PC4 is inhibited by phosphorylation. J Biol Chem 276 (2001) 16804-16809